Lotus Capital provides MJNA with USD2m equity-based line of credit
Medical Marijuana has signed closing documentation for a USD2m line of credit with Lotus Capital, a Chicago based private equity firm. The line of credit will be used as a reserve fund for product expansion of the Dixie X line of Cannabidoil (CBD) based products as well as to support


